SUMMARY
T he insulin-dependent diabetic syndromes of the BB Wistar rat and man have several phenomena in common implicating immune factors in the etiology of the pancreatic B-cell destruction. Evidence for cell-mediated immunity in the BB rat includes (1) the intense mononuclear cell infiltrate in the islets during active B-cell loss;
1 " 4 (2) modification and possible prevention of the syndrome by treatment with anti-lymphocyte serum; 5 (3) possible prevention by neonatal thymectomy 6 and by bone marrow transplantation from normal rats; 7 (4) the demonstration of passive transfer of insulitis by lymphocytes from dia-betic rats injected into nude mice; 8 and (5) the presence of lymphopenia before and after development of diabetes.
9 "
12
It has not been observed whether the BB rat diabetic syndrome is associated with humoral immunity. In fact, we have been unable to demonstrate islet cell cytoplasmic antibodies by immunofluorescence on frozen sections of the rat pancreas (A. Tingle and A. F. Nakhooda, unpublished observations). This contrasts with the well-documented presence of such circulating antibodies 13 -14 in 60% or more human insulin-dependent diabetics during the first year after diagnosis.
15
- 16 More recently, antibodies against the pancreatic islet cell plasma membrane have been identified in humans 17 and such islet cell surface antibodies (ICSA) are detectable in a radioligand assay.
18
- 19 This assay was used to determine if ICSA were present in the BB rat.
MATERIALS AND METHODS
Fourteen BB rats (5 male, 9 female) were obtained from Dr. P. Thibert (Animal Resources Division, Health Protection Branch, Ottawa, Ontario, Canada) before or shortly after onset of diabetes together with six male nondiabetic BB controls. In addition, we studied six male non-BB Wistar rats (M0llegarden, LI. Skensved, Denmark). Blood was sampled from the orbital sinus under light ether anesthesia at 3-11 days after onset of glycosuria. We also studied four diabetic BB rats from whom serial samples were taken up to 25 days after onset. Plasma samples were coded and stored at -20°C until later assay of glucose and antibodies. Total blood and spleen lymphocyte counts were also determined as the animals were donors for a passive transfer study. 8 Details are presented in Table 1 .
Islets of Langerhans were isolated by collagenase digestion of the pancreas from non-BB Wistar rats.
18 Suspensions of cells were prepared by dispersing the isolated islets with a Pasteur pipette after incubation in a Ca 2+ -free medium.
18
Spleen lymphocytes from non-BB Wistar rats were obtained by centrifugation on a Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) gradient. 19 A protein-A radioligand assay was used to detect islet cell and spleen lymphocyte antibodies.
- 20 Living 18 or paraformaldehyde-fixed 20 cells were 18 Each plasma sample was assayed in duplicate, the coefficient of variation being 10%. Results are given as mean ± SD and diabetic and control rats were compared using Student's t test.
RESULTS
The age of the BB rats at onset of diabetes was 82 ± 17 days. At the time of sampling, the mean plasma glucose was 353 ± 88 mg/dl (Table 1 ). In 12 of the 14 diabetic BB rats the binding of 125 l-protein-A to islet cells exceeded the mean and 2 SD of normal BB rat samples (Figure 1) . In a separate analysis the binding of 125 l-protein-A to islet cells incubated with plasma from non-BB Wistar rats was 1348 ± 187 cpm/5 x 10 4 cells (N = 6) compared with 1143 ± 243 cpm/5 x 10" cells from nondiabetic BB rats. Two diabetic rats (nos. 3 and 6) showed normal values in samples taken 3 days after onset. The 125 l-protein-A assay of antibodies bound to spleen lymphocytes revealed that 13 of 14 diabetic BB rats showed values above 2 SD from the mean of the BB Wistar controls (Figure 1) . A positive correlation was found between antibody binding to islet cells and spleen lymphocytes (r = 0.9240; P < 0.001) (Figure 2 ). Those rats without ICSA showed the lowest counts in spleen cells (rats 3 and 6). The 125 l-protein-A bound per islet cell was nearly 10 times that bound per spleen lymphocyte. The total extractable lymphocytes from blood and spleen was decreased by a factor of 3 in diabetic BB rats (Table 1) . No correlation existed between the binding of 125 l-protein-A to either spleen lymphocytes or islet cells and numbers of lymphocytes (r = 0.1919 and 0.1624, respectively). In four diabetic BB rats, 2-4 serial samples were obtained at the time of diagnosis. One rat was positive on days 1 and 7 but negative on day 16. Two rats remained positive on days 3 and 15, and on 8 and 25, respectively. One rat was negative on days 1 and 7; however, a sample on day 15 bound 125 Iprotein-A above the 2 x SD of controls. Studies are in progress to determine the natural history of ICSA in normal and diabetic BB Wistar rats.
DISCUSSION
This study demonstrates that the diabetic syndrome of the BB Wistar rat is associated with the presence of circulating antibodies to islet cell surface antigenic determinants. The antibodies were present in 12 of 14 (85%) rats studied 3-11 days after diagnosis. In one animal who was followed serially, earlier samples were within the control range, but at 15 days a rise in 125 l-protein-A counts occurred, while in another rat previously elevated values returned to the control range after 16 days (not shown). While further prospective studies will be necessary to determine the natural history of ICSA among BB rats, the present study provides a further analogy of the diabetic BB rat to that of insulin-dependent diabetes in man.
The transient character of islet cell surface and cytoplasmic antibodies in human insulin-dependent diabetes is well documented.
13 " 17 - 20 Additionally, there is heterogeneity among diabetics as to whether islet cell cytoplasmic surface or both antibodies are present. 21 The apparent lack of islet cell cytoplasmic antibodies in the BB rat, as reported anecdotally by several investigators, is not explained, and may be one distinguishing feature of the rat. The role of islet cell antibodies in B-cell destruction is as yet unclear. Cytoplasmic islet cell antibodies react with all endocrine islet cell types, 13>14>16 while only islet cell surface positive serum samples were cytotoxic to islet B-cells. 12 - 23 Although islet cell antibodies may develop after a previous B-cell disruption, evidence exists that they can alter B-cell function and integrity in vitro. 24 ' 25 In addition, serum from newly diagnosed diabetic children immunoprecipitates specific antigens from human islets. 26 Our preliminary experiments with radioactively labeled rat islet cell proteins suggest that diabetic BB rat sera are able to recognize similar antigens.
Antibodies to spleen lymphocytes were found in 13 of 14 diabetic BB rats. The direct correlation between 125 l-protein-A radioactivity in islet and spleen cells suggests a casual relationship. The larger binding to islet cells than to spleen lymphocytes and the lack of correlation between lymphocyte antibodies and total lymphocytes from blood and spleen suggest that the antibodies may be directed against a lymphocytic subpopulation. Work is in progress to determine whether diabetic BB rat autoantibodies recognize antigenic determinants common to islet cells and spleen lymphocytes. The lymphopenia which antedates and serves as a marker for susceptibility to insulitis 9 " 11 is apparently restricted to a T-lymphocyte subset. 12 It is an attractive hypothesis that lymphocyte antibodies may induce an imbalance between T-helper and suppressor subsets, and this results in autoimmune B-cell destruction.
